New York State Common Retirement Fund’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,319
Closed -$1.5K 3269
2025
Q1
$1.5K Hold
3,319
﹤0.01% 3161
2024
Q4
$1.67K Hold
3,319
﹤0.01% 3167
2024
Q3
$3K Hold
3,319
﹤0.01% 3158
2024
Q2
$3.31K Buy
3,319
+27
+0.8% +$30 ﹤0.01% 3254
2024
Q1
$4.87K Buy
3,292
+132
+4% +$150 ﹤0.01% 3216
2023
Q4
$3.44K Sell
3,160
-395
-11% -$433 ﹤0.01% 3228
2023
Q3
$4.2K Sell
3,555
-64,045
-95% -$87.1K ﹤0.01% 3241
2023
Q2
$95.3K Buy
+67,600
New +$93.4K ﹤0.01% 2887
2022
Q3
Sell
-907
Closed -$1K 3375
2022
Q2
$1K Sell
907
-68,222
-99% -$90K ﹤0.01% 3371
2022
Q1
$106K Buy
69,129
+207
+0.3% +$321 ﹤0.01% 3005
2021
Q4
$169K Sell
68,922
-228
-0.3% -$534 ﹤0.01% 2929
2021
Q3
$174K Sell
69,150
-34,750
-33% -$89.2K ﹤0.01% 2963
2021
Q2
$296K Buy
+103,900
New +$269K ﹤0.01% 2855
2020
Q2
Sell
-69,500
Closed -$58K 3249
2020
Q1
$58K Hold
69,500
﹤0.01% 2946
2019
Q4
$62K Hold
69,500
﹤0.01% 3099
2019
Q3
$68K Hold
69,500
﹤0.01% 3112
2019
Q2
$76K Hold
69,500
﹤0.01% 3165
2019
Q1
$91K Hold
69,500
﹤0.01% 2976
2018
Q4
$63K Sell
69,500
-9,939
-13% -$15.2K ﹤0.01% 3062
2018
Q3
$163K Hold
79,439
﹤0.01% 2915
2018
Q2
$143K Hold
79,439
﹤0.01% 3008
2018
Q1
$187K Hold
79,439
﹤0.01% 2759
2017
Q4
$149K Hold
79,439
﹤0.01% 2878
2017
Q3
$197K Hold
79,439
﹤0.01% 2776
2017
Q2
$219K Sell
79,439
-1
-0% -$3 ﹤0.01% 2803
2017
Q1
$240K Buy
79,440
+25,147
+46% +$71.4K ﹤0.01% 2703
2016
Q4
$171K Hold
54,293
﹤0.01% 2824
2016
Q3
$185K Hold
54,293
﹤0.01% 2783
2016
Q2
$124K Hold
54,293
﹤0.01% 2917
2016
Q1
$136K Sell
54,293
-4,560
-8% -$10.2K ﹤0.01% 2838
2015
Q4
$195K Hold
58,853
﹤0.01% 2786
2015
Q3
$143K Sell
58,853
-9,814
-14% -$25.4K ﹤0.01% 2931
2015
Q2
$201K Buy
+68,667
New +$266K ﹤0.01% 2917

Other funds holding LCTX